SafeScript NSW: what claims teams need to know
The NSW real-time prescription monitoring system explained for Injury Management Advisors, Claims Advisors and Wellbeing Specialists working NSW workers compensation and CTP claims.
SafeScript NSW is the NSW Government's real-time prescription monitoring system, run by NSW Health. It shows prescribers and pharmacists a patient's recent supply of monitored high-risk medicines. Clinicians are encouraged (not mandated) to check it. Access is limited to practitioners involved in the patient's care — insurers and claims teams cannot use it.
Key Takeaways
- Run by: NSW Health — official information at safescript.health.nsw.gov.au
- Checking: strongly encouraged for NSW prescribers and pharmacists, but not mandatory (unlike Victoria and Queensland)
- Monitored medicines: Schedule 8 medicines and certain high-risk Schedule 4 medicines — see the official NSW list for specifics
- Access: prescribers and pharmacists involved in the patient’s care only; no insurer, employer or legal access
- For NSW claims: medication information reaches a workers compensation or CTP file only through the worker’s authority and registered practitioners — SIRA guidance governs what may be requested
How SafeScript NSW works
When a NSW prescriber writes, or a pharmacist dispenses, a monitored medicine, SafeScript NSW surfaces the patient's recent monitored-medicine history — across all prescribers and pharmacies — and raises alerts for high-risk circumstances. It launched state-wide in 2021 and is operated by NSW Health.
The monitored list covers the high-risk categories: Schedule 8 medicines (opioids such as oxycodone, morphine and tapentadol, and psychostimulants) plus certain high-risk Schedule 4 medicines. The authoritative monitored-medicines list is published by NSW Health.
Is checking mandatory in NSW?
No — and this is the main difference from Victoria and Queensland. NSW encourages practitioners to check SafeScript NSW; Victoria and Queensland mandate checking in most circumstances. In practice this means a NSW dispense record can still involve prescribers who did not consult the system, though usage has grown steadily.
Who can access it?
Prescribers and pharmacists involved in the patient's care. Not insurers, not employers, not lawyers, not independent examiners. This is a legal restriction, not a policy preference, and no claims authority overrides it.
NSW practitioners seeking access
Register through SafeScript NSW (NSW Health). This page is written for claims professionals, not prescribers.
What it means for NSW claims
For a NSW workers compensation claim (regulated by SIRA) or CTP claim, SafeScript NSW changes the clinical environment around the claimant — high-risk prescribing is more visible to the treating team, and multiple-prescriber patterns get flagged where they used to run silent.
What it does not change: how medication information reaches the claim. That path remains the worker's authority on the claim form, requests to treating providers under SIRA's claims guidance, and dispense records lawfully obtained by registered pharmacists. If the medication picture matters on the claim — high-cost, long-tail, or drifting — that is the path that produces it.
Where Allmeds fits in
Allmeds retrieves medication history via prescribers and pharmacists involved in the patient's care, and reviews what comes back and turns it into evidence your team can act on.
See what a complete medication picture looks like on a claim
On NSW claims, Allmeds provides the lawful equivalent of the visibility clinicians get — the medication history on the claim, obtained through registered pharmacists and reviewed properly.
Related pages
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.